FDA Adverse Event Injury Summary report: N

CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM

MDR report key: 24469982 · Received February 27, 2026

Report

Report Number
9612169-2026-00445
Event Type
Injury
Date Received
February 27, 2026
Report Date
February 27, 2026
Manufacturer
ALCON LABORATORIES IRELAND LTD.
Product Code
POE
UDI-DI
00380652406819
PMA / PMN Number
P190018
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WY, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

A PRODUCT WAS NOT RETURNED FOR ANALYSIS. COMPLAINT HISTORY AND PRODUCT HISTORY RECORDS WERE REVIEWED AND DOCUMENTATION INDICATED THE PRODUCT MET RELEASE CRITERIA. ROOT CAUSE HAS NOT BEEN IDENTIFIED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A NON-HEALTH CARE PROFESSIONAL REPORTED THAT FOLLOWING THE INTRAOCULAR LENS (IOL) THE PATIENT EXPERIENCED POOR QUALITY OF VISION AND DOUBLE VISION. CLINICAL REASON MENTIONED WAS DECREASED CONTRAST, UPDATE IN REFRACTION NOT BENEFICIAL. ADDITIONAL INFORMATION RECEIVED AND STATED THAT THE PATIENT EXPERIENCED GLARE, STROBE LIGHTS AND UNCLEAR VISION. THE INTRAOCULAR LENS (IOL) EXCHANGE HAS BEEN PERFORMED DUE TO PATIENT¿S DISSATISFACTION. THE EXCHANGE WAS PERFORMED BY ANOTHER SURGEON. THERE WAS NO FURTHER IMPACT TO THE PATIENT. THE PATIENT ISSUE HAD BEEN RESOLVED POST IOL EXCHANGE. THE SURGEON¿S PROGNOSIS WAS EXCELLENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533216 CLAREON VIVITY EXTENDED VISION UV ABSORBING IOL W/AUTONOME DELIVERY SYSTEM EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS POE ALCON LABORATORIES IRELAND LTD. CCAET0 25835144 00380652406819

Patients

Seq Age Sex Outcome Treatment
1 NA Female Required Intervention CLAREON MONARCH IV IOL DELIVERY SYSTEM, INJECTOR.| DUOVISC VISCOELASTIC SYSTEM.| LI61AO 20.0.| MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE C.